Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bulletin Du Cancer|April 27, 2010
[New therapeutics strategies in renal cell carcinoma]J-B Meric, B Billemont, O RixeBulletin Du Cancer|May 13, 2009
[Angiogenesis: a new therapeutic target of thoracic and laryngopharyngeal carcinoma]L Taillade, I Alexandre, B Billemont, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 8, 2008
[Regression of vena cava tumour thrombus in response to sorafenib]F Thibault, H Izzedine, V Sultan, et al.British Journal of Cancer|October 9, 2008
Blood glucose levels in patients with metastatic renal cell carcinoma treated with sunitinibB Billemont, J Medioni, L Taillade, et al.British Journal of Cancer|July 7, 2012
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?N Pécuchet, C Lebbe, O Mir, et al.Journal of Pharmaceutical and Biomedical Analysis|March 13, 2009
Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practiceB Blanchet, B Billemont, J Cramard, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC NetworkG G Malouf, P Camparo, S Oudard, et al.Annals of the Rheumatic Diseases|June 24, 2010
Systemic mastocytosis and bone involvement in a cohort of 75 patientsS Barete, N Assous, C de Gennes, et al.Pageof 1